|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09886 DINGDANG HEALTH
Nominal 
0.880 +0.010 (+1.149%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 2,326,907 | 2.602% | 2,267,894 | 2,247,282 | 1,989,776 | 1,643,608 |
| Cost of Sales | (1,511,098) | -0.334% | (1,516,158) | (1,564,369) | (1,325,104) | (1,139,934) |
| Gross Profit | 815,809 | 8.523% | 751,736 | 682,913 | 664,672 | 503,674 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (677) | -69.213% | (2,199) | 950 | (362,994) | (862,163) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (20,006) | (20,314) | |
| Share of Results of Asso. & JCEs | 0 | -- | (1,177) | (234) | 0 | 0 | |
| Profit / (Loss) before Taxation | (44,246) | -47.115% | (83,664) | (113,632) | (581,515) | (1,092,869) | |
| Taxation | (7,775) | 26.691% | (6,137) | (3,719) | (4,394) | (5,527) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 350 | -93.409% | 5,310 | 4,777 | 7,844 | 10,892 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (51,671) | -38.844% | (84,491) | (112,574) | (578,065) | (1,087,504) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (9,748) | 0.144% | (9,734) | (12,573) | (4,140) | 12,394 |
| Depreciation & Amortisation | 66,626 | -4.512% | 69,774 | 67,377 | 66,475 | 62,482 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -4.000 | -33.333% | -6.000 | -8.000 | -92.000 | -339.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.255 | -- | 1.450 | 1.582 | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -51,671 |
| %Change | -38.844% |
| EPS / (LPS) | RMB -0.040 |
| NBV Per Share (¥) | RMB 1.255 |